Differential regulation of eotaxin expression by TNF-alpha and PMA in human monocytic U-937 cells

Am J Physiol. 1998 Sep;275(3):L601-10. doi: 10.1152/ajplung.1998.275.3.L601.

Abstract

Regulation of eotaxin expression was investigated in U-937 cells, a human monocyte-like cell line. Eotaxin mRNA was induced by tumor necrosis factor-alpha (TNF-alpha; 0.1-100 ng/ml) and phorbol 12-myristate 13-acetate (PMA; 0.01-1 microM). PMA-induced eotaxin mRNA expression was of greater magnitude and was maximal at a later time point than TNF-alpha-induced expression (16 h vs. 2 h after stimulation), which was consistent with eotaxin protein expression detected by immunocytochemistry. Dexamethasone (0.01-10 microM) decreased eotaxin mRNA expression in both TNF-alpha- and PMA-stimulated U-937 cells. PMA-induced eotaxin mRNA expression was inhibited by cycloheximide (10 microg/ml), whereas TNF-alpha-induced expression was not. The protein kinase C (PKC) inhibitor staurosporine (10-50 nM) inhibited PMA-induced eotaxin mRNA expression, whereas TNF-alpha-induced expression was enhanced by this reagent. These results suggest that eotaxin expression can be induced by more than one mechanism: the PMA-triggered pathway is mediated by PKC activation and requires new protein synthesis, whereas the TNF-alpha-triggered pathway is independent of PKC and protein synthesis. TNF-alpha- and PMA-induced pathways are both associated with nuclear factor-kappaB, because its binding activity was enhanced in the presence of these stimuli, and both pathways were limited by its inhibitor, diethyldithiocarbamate.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma
  • Cell Line
  • Cells, Cultured
  • Chemokine CCL11
  • Chemokines, CC*
  • Chemotactic Factors, Eosinophil / genetics
  • Cytokines / biosynthesis
  • Cytokines / genetics*
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / immunology*
  • Gene Expression Regulation* / drug effects
  • Humans
  • Interferon-gamma / pharmacology
  • Interleukin-1 / pharmacology
  • Interleukin-4 / pharmacology
  • Kinetics
  • Lipopolysaccharides / pharmacology
  • Lung Neoplasms
  • Monocytes / cytology
  • Monocytes / drug effects
  • Monocytes / immunology*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Tetradecanoylphorbol Acetate / pharmacology
  • Time Factors
  • Transcription, Genetic / drug effects
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • CCL11 protein, human
  • Chemokine CCL11
  • Chemokines, CC
  • Chemotactic Factors, Eosinophil
  • Cytokines
  • Interleukin-1
  • Lipopolysaccharides
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Interferon-gamma
  • Tetradecanoylphorbol Acetate